+44 (0) 20 3311 7700
Search our consultants’ directory
To book an appointment please call +44 (0)20 3311 7700 or email imperial.private.healthcare@nhs.net
Biography
Dr Natalie Direkze was educated in London before completing an undergraduate degree in natural sciences at Cambridge University. During this course she realised that her interest lay in the medical specialties and subsequently studied medicine at St Mary’s Hospital (Imperial College, London). Following junior medical posts in London she completed a PhD in adult stem cell biology at Cancer Research UK in 2006 (Imperial College) prior to taking up a post as clinical lecturer at Bart’s and the London NHS Trust from 2007 to 2009. She was appointed to Frimley Park Hospital NHS Foundation trust as a consultant in 2009. She moved from Frimley Park to St Mary’s Hospital in 2015 where she continues her practice as a consultant gastroenterologist and general physician.
Dr Natalie Direkze has an interest in luminal gastroenterology. She has a particular interest in inflammatory bowel disease and also upper gastro-intestinal disorders. She has developed an interest in Barrett’s oesophagus and the newer treatments available for this such as radio-frequency ablation.
She also has a keen interest in endoscopy and performs gastroscopy, colonoscopy (she is a bowel cancer screening programme accredited colonoscopist) and capsule endoscopy. She also sees patients with other gastrointestinal symptoms and disorders such as change in bowel habit, anaemia, reflux symptoms and gastrointestinal bleeding.
Biography
Dr Hoare trained at Cambridge University and St Mary’s Hospital Medical School, qualifying in 1993. He undertook a PhD as an MRC research fellow in viral hepatitis and gene therapy from 1998 until 2001. His clinical gastroenterology training was in various north London hospitals including a prolonged attachment at St Mark’s Hospital where he was the first Fujinon Advanced Endoscopy Fellow in 2006, before being appointed as consultant at St Mary’s.
He is head of endoscopy for the Imperial College hospital’s. In 2010 he was awarded a British Society of Gastroenterology Travelling Fellowship to study advanced endoscopic techniques at the National Cancer Centre in Tokyo and he is a medical adviser to the Barrett’s Oesophagus Campaign, a registered charity which works toward improving the care of patients with Barrett’s oesophagus and oesophageal cancer. His clinical practice encompasses all aspects of gastroenterology including inflammatory bowel disease and functional problems such as irritable bowel.
His specialist endoscopic interests include the detection and treatment of early gastrointestinal cancer and he is an accredited colonoscopist on the National Bowel Cancer Screening programme. Other interests include the management of difficult gastrointestinal bleeding, small bowel capsule endoscopy and enteroscopy.
Biography
Professor Shahid Khan is professor of practice (hepatology) at Imperial College London. He is an internationally renowned liver specialist. He has lectured on liver disease nationally and internationally at hepatology and gastroenterology conferences, including state of the art and invited presentations. He is the lead author on the National guidelines for biliary cancer and is co-author on the International and European guidelines. He has published extensively in the medical literature, including original research articles, reviews and book chapters.
Prof Khan is an accredited Royal College of Physicians educator and enjoys a large teaching role, at both undergraduate and postgraduate level. He has supervised several PhD/MD studies in liver disease and is also deputy admissions tutor for Imperial College Medical School, as well as director of the gastroenterology & hepatology Bsc degree programme at Imperial College London. He was also previously director of clinical studies at St Mary’s Hospital. He is a member of the Association of Physicians of GB and Ireland, the British Medical Association, the British Association for the Study of the Liver, the British Society of Gastroenterology, the European Association for the Study of the Liver, the American Association for the Study of the Liver Diseases and International Liver Cancer Association, where he has served as the chair of a special interest group and he is currently chair of cholangiocarcinoma UK.
Additional languages spoken: Urdu
Biography
Dr John Martin was educated at Girton College, Cambridge and King’s College, London. He trained as a gastroenterologist within North West London and obtained an MD investigating novel methods for colorectal cancer screening. He was appointed as a consultant in 2002 and moved to Charing Cross Hospital in 2006.
He has a particular interest in screening for colorectal cancer and is Director of the West London Bowel Cancer Screening Centre, based at Charing Cross. He has a passion for colonoscopy and performs advanced polypectomy as well as teaching colonoscopy both within Imperial College Healthcare NHS Trust and also at National screening centres.
He is a bowel cancer screening accredited colonoscopist and an examiner for BCSP colonoscopy accreditation. He runs a general gastroenterology clinic, treating patients with all luminal gastroenterological conditions, although has a special interest in inflammatory bowel disease.
Dr Simon Peake
Consultant gastroenterologistBiography
Dr Simon Peake trained at St Mary’s Hospital Medical School.
Biography
Dr Ruban completed his medical degree at Imperial College London, before completing his specialist training in London. He has a masters (MSc) in medical education at UCL and a PhD at Imperial College. He has experience of conducting an NIHR funded multicentre randomised controlled trial and won the prestigious integrated healthcare scholarship in 2021 from the International Federation for the Surgery of Obesity and Metabolic Disorders (IFSO).
He is on the British Society of Gastroenterology (BSG) small bowel and nutrition committee and has specialist interests in nutrition and inflammatory bowel disease.
Biography
Dr Evangelos Russo was appointed as a consultant gastroenterologist at Imperial College Healthcare NHS Trust in 2017. He previously completed his specialist training in north west Thames, and a PhD degree at Imperial College London focused on inflammatory bowel disease. He has a strong interest in colonoscopy and polypectomy and is a core member of the lower GI cancer multi-disciplinary team. He has a wide portfolio of endoscopic procedures including diagnostic and therapeutic gastroscopy, BRAVO pH monitoring, diagnostic and therapeutic colonoscopy and polypectomy as well as endoscopic full-thickness resection.
His other clinical interest and focus of clinical research is inflammatory bowel disease as well as microscopic colitis, a common but often underdiagnosed cause of chronic diarrhoea. He also has wide experience in the investigation and management of a wide range of GI conditions including abdominal pain, dyspepsia and reflux, change in bowel habit, GI bleeding and irritable bowel syndrome.
Additional languages spoken: French, Greek
HIs publications include:
EA Russo, SA Khan, R Janisch, RN Gunn, EA Rabiner, SA Taylor, PM Matthews, TR Orchard. The role of 18F-fluorodeoxyglucose positron emission tomography in the monitoring of inflammatory activity in Crohn’s disease. Inflamm Bowel Dis 2016 – In press
A Plumb, A Menys, EA Russo, D Prezzi, G Bhatnagar, R Vega, S Halligan, TR Orchard, SA Taylor. Magnetic resonance imaging-quantified small bowel motility is a sensitive marker of response to medical therapy in Crohn’s disease. Aliment Pharmacol Ther. 2015 Aug;42(3):343-55
P Kennedy, EA Russo, N Kumar, N Powell, P Vlavianos, A Thillainayagam, D Bansi, D Westaby. Effectiveness of prophylactic pancreatic stents in preventing post-ERCP pancreatitis: A two-year retrospective controlled study in a tertiary centre in London.
Surg Endosc. 2010 Aug;24(8):1923-8
EA Russo, M Iacucci, JO Lindsay, S Campbell, JP Hamlin, TR Orchard, N Arebi, AL Hart, SM Gabe, MR Jacyna, J Nightingale, M O’Connor, AW Harris, C O’Morain, S Ghosh.
Survey regarding the use of adalimumab as maintenance therapy in Crohn’s disease in England and Ireland.
Eur J Gastroenterol Hepatol. 2010 Mar;22(3):334-9.
EA Russo, AW Harris, S Campbell, J Lindsay, A Hart, N Arebi, A Milestone, HH Tsai, J Walters, M Carpani, D Westaby, A Thillainayagam, D Bansi, S Ghosh.
Experience of maintenance infliximab therapy for refractory ulcerative colitis in England.
Aliment Pharmacol Ther. 2009 Feb 1;29(3):308-14.